Posts Tagged ‘Josep M. Campistol’

Wednesday February 28th, 2018

Hospital Clínic, Mobile World Capital Barcelona and AIS Channel present the first technological operating theatre with remote assistance as part of 5GBarcelona

Hospital Clínic de Barcelona and Mobile World Capital Barcelona have presented today, as part of the GSMA Mobile World Congress, a pilot project that will make it possible to provide remote assistance for surgical procedures in real time. Josep M. Campistol, managing director of  Hospital Clínic de Barcelona, Carlos Grau, managing director of MWCapital, and Antonio de Lacy, head of the Gastrointestinal Surgery Deaprtment at Hospital Clínic de Barcelona and the founder of AIS Channel, took part in the event. Read the rest of this entry »

Comments Closed
Thursday January 26th, 2017

Scientists at Salk Institute have made breakthroughs in the integration of human cells into embryos of a different species

Human iPS cells (green) contributed to a developing heart of 4-week-old pig embryo (Image: Salk Institute)Scientists at Salk Institute for Biological Studies in California have made breakthroughs on multiple fronts in the race to integrate pluripotent stem cells from one species into the early-stage development of another. This will allow to study the embryonic development of an organism, diseases, test new therapeutic drugs and the possibly grow transplantable. Dr. Juan Carlos Izpisúa, professor in Salk’s Gene Expression Laboratory, leads this study published in today’s issue of the journal Cell. Dr. Josep M. Campistol, CEO and nephrologist in Hospital Clínic and researcher in IDIBAPS, and scientists from the Catholic University of Murcia (UCAM), the Pedro Guillén Foundation, the CEMTRO Clinic in Madrid and the University of Murcia, have also participated.

Read the rest of this entry »

Comments Closed
Thursday December 15th, 2016

New cellular reprogramming technique counters hallmarks of aging

Scientists from Salk Institute for Biological Studies showed that One clue to halting or reversing aging lies in the study of cellular reprogramming, a process in which the expression of four genes known as the Yamanaka factors allows scientists to convert any cell into induced pluripotent stem cells (iPSCs) Like embryonic stem calls, iPSCs are capable of dividing indefinitely and becoming any cell type present in our body. Dr. Juan Carlos Izpisúa Belmonte, professor in Salk’s Gene Expression Laboratory, is the senior author of the paper, published in Cell, in which also participated Dr. Josep Maria Campistol, CEO and nephrologist in Hospital Clínic, and researcher in IDIBAPS. Scientists from Universidad Católica de Murcia, among others, have also been involved. Read the rest of this entry »

Comments Closed
Thursday November 24th, 2016

Two Clinic professionals receive the Fundació Catalunya-La Pedrera “Talents” grants

Last Wednesday, November 23, was held in the Auditorium La Pedrera the 5th ceremony of delivery of the  Fundació Catalunya-La Pedrera “Talents” Program grants, in which Hospital Clínic participates for the first time with the granting of two Scholarships. The event was chaired by the Health Minister of the Generalitat de Catalunya, Antoni Comín, who was accompanied by Ms. Marta Lacambra, CEO of the Catalunya-La Pedrera Foundation; Dr. Jordi Ara, ICS North Metropolitan Area Manager; And Dr. Josep Mª Campistol, CEO of the Hospital Clínic, who was also chosen godfather of this year’s promotion.

Read the rest of this entry »

Comments Closed
Wednesday November 23rd, 2016

Successful participation in the commemoration of the 20th anniversary of IDIBAPS

Last Friday, November 18th, the celebration of the 20th anniversary of IDIBAPS was held. About 300 people gathered in the inner courtyard Beatriu de Pinós to listen to the speeches of Ramon Gomis, director of IDIBAPS, Francesc Subirada, general director of Research, Josep M. Campistol, general director of Hospital Clínic, Jaume Reventós, responsible of the Operations and Institutional Relations Department of the General Directorate of Research and Innovation of the Department of Health and Elías Campo, research director of Hospital Clínic and director of the Clinic Foundation for Biomedical Research.

Read the rest of this entry »

Comments Closed
Wednesday November 16th, 2016

New gene-editing technology partially restores vision in blind animals

Salk Institute researchers, in collaboration, among others, with researchers from Hospital Clínic-IDIBAPS and the Universidad Católica San Antonio  de Murcia, have discovered a holy grail  for gene editing: the ability to, for the first time, insert DNA at a target location into the non-dividing cells that make up the majority of adult organs and tissuess. The technique, which the team showed was able to partially restore visual responses in blind rodents, will open new avenues for basic research and a variety of treatments, such as for retinal, heart and neurological diseases. The study, led by Dr. Juan Carlos Izpisúa-Belmonte, a professor in Salk’s Gene Expression Laboratory, has been published today in the journal Nature.

Read the rest of this entry »

Comments Closed
Page 1 of 212